An idem trend was observed for 177Lu-labeled HTK01169, a PSMA-617 derivative containing N-[4-(p-iodophenyl)butanoyl]-Glu, which showed an increased tumor and kidney retention compared to PSMA-617. This evidence concerns the gene FOLH1 and neoplasm.